Centering their discussion on cornerstone therapies, expert hematologist-oncologists consider the treatment paradigms of essential thrombocythemia and polycythemia vera. Rami Komrokji, M.D.: Once we ...

• Hgb > 18.5 g/dl (men) or > 16.5 g/dl (women) or Hgb or Hct > 99th percentile of method-specific reference range for age, sex or altitude of residence or Hgb > 17 g/dl (men) or > 15 g/dl (women) if ...

This panel was moderated by Ryan McDonald and featured Dr. Aaron Gerds, from Cleveland Clinic, and Dr. Douglas Tremblay, from Mount Sinai, who answered questions about essential thrombocythemia (ET).

The myeloproliferative neoplasms (MPN) are a heterogeneous group of hematologic diseases characterized by excessive production of cells belonging to the myeloid lineage in the bone marrow. They are ...

Myeloproliferative neoplasms are blood cancers that cause excess production of blood cells from myeloid stem cells. Common types include chronic myeloid leukemia (CML), polycythemia vera, essential ...

The original MYSEC dataset included 781 patients from 16 institutions [30, 31]. At the time of last update (June 2021), we have collected a total of 1258 SMF patients, enrolled from 19 centers across ...

A recent study identified trends in blood counts, but did not find statistically significant associations between achieving hematological remission and clinical outcomes in polycythemia vera (PV) or ...

Chronic Arm Morbidity After Curative Breast Cancer Treatment: Prevalence and Impact on Quality of Life PURPOSE: To examine the utility of polycythemia rubra vera-1 (PRV-1)–specific reverse ...

New findings from a small study are suggesting that time to leukemic transformation may be driven by distinct time-dependent molecular mechanisms. While polycythemia vera (PV) and essential ...

More than half of patients with polycythemia vera and essential thrombocythemia experienced partial molecular response after treatment with hydroxyurea, according to study results. Researchers from ...

Polycythemia vera and essential thrombocythemia are the most common chronic myeloproliferative neoplasms; their molecular basis has been appreciated only recently and is briefly discussed in this ...

Chronic Arm Morbidity After Curative Breast Cancer Treatment: Prevalence and Impact on Quality of Life PURPOSE: To examine the utility of polycythemia rubra vera-1 (PRV-1)–specific reverse ...